134 related articles for article (PubMed ID: 8492071)
1. Measurement of insulin-like growth factor-II in human plasma using a specific monoclonal antibody-based two-site immunoradiometric assay.
Crosby SR; Anderton CD; Westwood M; Holly JM; Cwyfan Hughes SC; Gibson M; Morrison CA; Young RJ; White A
J Endocrinol; 1993 Apr; 137(1):141-50. PubMed ID: 8492071
[TBL] [Abstract][Full Text] [Related]
2. Characterization of new monoclonal antibodies to human insulin-like growth factor-II and their application in western immunoblot analysis.
Enjoh T; Hizuka N; Perdue JF; Takano K; Fujiwara H; Higashihashi N; Marumoto Y; Fukuda I; Sakano K
J Clin Endocrinol Metab; 1993 Aug; 77(2):510-7. PubMed ID: 7688378
[TBL] [Abstract][Full Text] [Related]
3. Free insulin-like growth factor I (IGF-I) and IGF-II in human saliva.
Costigan DC; Guyda HJ; Posner BI
J Clin Endocrinol Metab; 1988 May; 66(5):1014-8. PubMed ID: 3360895
[TBL] [Abstract][Full Text] [Related]
4. The effect of recombinant IGF-I on anterior pituitary function in healthy volunteers.
Trainer PJ; Holly J; Medbak S; Rees LH; Besser GM
Clin Endocrinol (Oxf); 1994 Dec; 41(6):801-7. PubMed ID: 7889617
[TBL] [Abstract][Full Text] [Related]
5. Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.
Camacho-Hübner C; Woods KA; Miraki-Moud F; Hindmarsh PC; Clark AJ; Hansson Y; Johnston A; Baxter RC; Savage MO
J Clin Endocrinol Metab; 1999 May; 84(5):1611-6. PubMed ID: 10323388
[TBL] [Abstract][Full Text] [Related]
6. The effects of recombinant human IGF-I administration on concentrations of acid labile subunit, IGF binding protein-3, IGF-I, IGF-II and proteolysis of IGF binding protein-3 in adolescents with insulin-dependent diabetes mellitus.
Cheetham TD; Holly JM; Baxter RC; Meadows K; Jones J; Taylor AM; Dunger DB
J Endocrinol; 1998 Apr; 157(1):81-7. PubMed ID: 9614361
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
Freda PU; Post KD; Powell JS; Wardlaw SL
J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
[TBL] [Abstract][Full Text] [Related]
8. Measurement of free insulin-like growth factor-I using immunoradiometric assay.
Takada M; Nakanome H; Kishida M; Hirose S; Hasegawa T; Hasegawa Y
J Immunoassay; 1994 Aug; 15(3):263-76. PubMed ID: 7523455
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome.
Camacho-Hübner C; Rose S; Preece MA; Sleevi M; Storr HL; Miraki-Moud F; Minuto F; Frystyk J; Rogol A; Allan G; Sommer A; Savage MO
J Clin Endocrinol Metab; 2006 Apr; 91(4):1246-53. PubMed ID: 16403822
[TBL] [Abstract][Full Text] [Related]
10. Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.
Drugs R D; 2005; 6(2):120-7. PubMed ID: 15777106
[TBL] [Abstract][Full Text] [Related]
11. Size heterogeneity of circulating growth hormone in acromegaly. "Big-big" GH forms are associated with inappropriately low IGF-I levels.
Arosio M; Nissim M; Ballabio M; Orefice R; Bazzoni N; Faglia G
Acta Endocrinol (Copenh); 1991 Aug; 125(2):150-9. PubMed ID: 1897332
[TBL] [Abstract][Full Text] [Related]
12. Determination of free insulin-like growth factor-I in human serum: comparison of ultrafiltration and direct immunoradiometric assay.
Frystyk J; Ivarsen P; Støving RK; Dall R; Bek T; Hagen C; Ørskov H
Growth Horm IGF Res; 2001 Apr; 11(2):117-27. PubMed ID: 11472078
[TBL] [Abstract][Full Text] [Related]
13. Effects of passive immunization of growing guinea-pigs with an insulin-like growth factor-I monoclonal antibody.
Kerr DE; Laarveld B; Manns JG
J Endocrinol; 1990 Mar; 124(3):403-15. PubMed ID: 2159044
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans.
Mauras N; Doi SQ; Shapiro JR
J Clin Endocrinol Metab; 1996 Jun; 81(6):2222-6. PubMed ID: 8964855
[TBL] [Abstract][Full Text] [Related]
15. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
[TBL] [Abstract][Full Text] [Related]
16. The effects of recombinant human insulin-like growth factor-I (IGF-I) administration on the levels of IGF-I, IGF-II and IGF-binding proteins in adolescents with insulin-dependent diabetes mellitus.
Cheetham TD; Taylor A; Holly JM; Clayton K; Cwyfan-Hughes S; Dunger DB
J Endocrinol; 1994 Aug; 142(2):367-74. PubMed ID: 7523562
[TBL] [Abstract][Full Text] [Related]
17. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome).
Savage MO; Blum WF; Ranke MB; Postel-Vinay MC; Cotterill AM; Hall K; Chatelain PG; Preece MA; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Dec; 77(6):1465-71. PubMed ID: 7505286
[TBL] [Abstract][Full Text] [Related]
19. Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system.
Thrailkill K; Quattrin T; Baker L; Litton J; Dwigun K; Rearson M; Poppenheimer M; Kotlovker D; Giltinan D; Gesundheit N; Martha P
J Clin Endocrinol Metab; 1997 Apr; 82(4):1181-7. PubMed ID: 9100593
[TBL] [Abstract][Full Text] [Related]
20. Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand.
Bang P; Eriksson U; Sara V; Wivall IL; Hall K
Acta Endocrinol (Copenh); 1991 Jun; 124(6):620-9. PubMed ID: 2068892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
